Gyeonggi-do, South Korea

Jeong Haing Heo


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Jeong Haing Heo and His Contribution to Autoimmune Disease Treatment

Introduction: Jeong Haing Heo, an inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of biotechnology. With a focus on developing targeted therapies for autoimmune diseases, Heo's research and innovations highlight the critical intersection of science and medicine.

Latest Patents: Jeong Haing Heo holds a patent for an FcRn-specific human antibody and composition aimed at treating autoimmune diseases. This innovative invention describes a human antibody that is specifically designed to target FcRn, a receptor with a high affinity for immunoglobulin G (IgG). The patent outlines the production method for the antibody, as well as its application in a composition for treating autoimmune diseases and diagnosing related conditions. By binding to FcRn non-competitively with IgG, this antibody can help reduce serum auto-antibody levels, offering potential therapeutic benefits for those suffering from autoimmune disorders.

Career Highlights: Heo's career is marked by his affiliation with Hanall Biopharma Co., Ltd., a company known for its dedication to developing innovative biopharmaceuticals. Through his work, he has contributed to advancing the understanding and treatment of complex medical conditions, positioning him as a vital figure in the field of immunology.

Collaborations: During his career, Jeong Haing Heo has collaborated with esteemed colleagues such as Sung Wuk Kim and Seung Kook Park. These collaborations have not only fostered a productive research environment but have also played a crucial role in enhancing the impact of their collective work on the scientific community.

Conclusion: Jeong Haing Heo is an exemplary innovator whose efforts are paving the way for new treatments for autoimmune diseases. His patented FcRn-specific human antibody represents a significant advancement in biopharmaceuticals, demonstrating the power of targeted therapeutics in addressing complex health challenges. As the landscape of medicine continues to evolve, Heo's contributions will undoubtedly remain influential in the quest for effective solutions for autoimmune conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…